Source: Arriaga, M. E., Vajdic, C. M., MacInnis, R. J., Canfell, K. , Magliano, D. J., Shaw, J. E., Byles, J. E., Giles, G. G., Taylor, A. W., Gill, T. K., Hirani, V. , Cumming, R. G., Mitchell, R. P., Banks, E. , Marker, J. , Adelstein, B. and Laaksonen, M. A. (2019), The burden of pancreatic cancer in Australia attributable to smoking. Med. J. Aust., 210: 213-220. doi:10.5694/mja2.12108
- The known The future pancreatic cancer burden attributable to tobacco smoking has not been estimated in Australia.
- The new Nearly 22% of the future burden of pancreatic cancer is attributable to current and former smoking, 15% (5500 cases over the next 10 years) to current smoking alone. The smoking‐related burden of pancreatic cancer is markedly higher for men and for people under 65.
- The implications Reducing smoking rates among men and people under 65 would have the greatest impact on reducing the future burden of pancreatic cancer in Australia.
To read the full text, please visit: https://www.issup.net/node/3604